[{"Assets_0_Q3_USD":416652000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-80155000.0,"NetIncomeLoss_1_Q3_USD":-174351000.0,"NetIncomeLoss_3_Q3_USD":-266875000.0,"StockholdersEquity_0_Q3_USD":-197295000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":65686000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":215947000.0,"Ticker":"IRWD","CIK":"1446847","name":"IRONWOOD PHARMACEUTICALS INC","OfficialName":"Ironwood Pharmaceuticals Inc. Class A Common Stock","form":"10-Q","period":"20180930","fy":"2018.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1913848067.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20181106"}]